Acute interstitial pneumonitis
Rare, severe lung disease of unknown cause with rapid progression.
Wikipedia / Wikimedia Commons
Acute interstitial pneumonitis is a rare, serious lung condition that strikes people who were previously healthy. It falls under the umbrella of both interstitial lung disease and acute respiratory distress syndrome (ARDS). The term "acute interstitial pneumonia" is reserved for cases where ARDS appears suddenly, without any known trigger, and follows a fast-moving clinical course. This sets it apart from chronic forms of interstitial pneumonia, like idiopathic pulmonary fibrosis. No proven treatment exists, so care mainly focuses on supportive measures.
**Symptoms and signs** The main symptoms include a cough that brings up thick mucus, fever, and trouble breathing. These usually develop over one to two weeks before someone seeks medical help. Fluid buildup can create a sensation like drowning. Breathing difficulties can quickly worsen to the point where a person cannot breathe without support—this is respiratory failure. The disease typically moves fast, often requiring hospitalization and a ventilator just days to weeks after the first cough, fever, or breathing trouble appears. Before the illness starts, some people also experience muscle aches, fatigue, and chills. When listening to the lungs, doctors commonly hear rapid breathing and crackling sounds.
**Diagnosis** A key clue is the rapid shift from initial symptoms to respiratory failure. A chest X-ray showing ARDS—fluid in the tiny air sacs (alveoli) in both lungs—is necessary for diagnosis. A lung biopsy is also required, revealing a pattern called organizing diffuse alveolar damage. This damage involves widespread, non-localized injury to the alveoli, marked swelling of the alveolar walls with inflammatory cells, growth of fibroblasts, occasional hyaline membranes, and thickening of the alveolar walls. The septa are lined with abnormal, overgrown type II pneumocytes, causing airspaces to collapse. Other tests, like basic blood work, blood cultures, and bronchoalveolar lavage, help rule out similar conditions, but the patient's history, X-ray, and biopsy are essential. The clinical picture looks like ARDS, but acute interstitial pneumonitis differs because its cause is unknown.
**Treatment** Care is mainly supportive. Management in an intensive care unit is standard, and many patients need a ventilator. Doctors often try corticosteroids, though their effectiveness is unproven. For some patients w
- first described
- 1935 by Louis Hamman and Arnold Rich
- also known as
- Hamman–Rich syndrome
- field
- Pulmonology
- affected population
- People older than 40 years; men and women equally
- key feature
- Rapid progression from initial symptoms to respiratory failure
- median survival
- 1+1⁄2 months
- six-month mortality
- 60%
Lore & Background
Acute interstitial pneumonitis was first described in 1935 by Louis Hamman and Arnold Rich, who gave it the name Hamman–Rich syndrome. The disease occurs most frequently among people older than forty years old and affects men and women equally. There are no known risk factors, though smoking is implicated in the clinical behavior of the disease.
Reader's Guide
Acute interstitial pneumonitis is significant as a rare, rapidly progressive lung disease that often leads to respiratory failure within days to weeks of initial symptoms. Its diagnosis requires a chest X-ray showing ARDS and a lung biopsy demonstrating organizing diffuse alveolar damage, with no identifiable trigger. The condition has no proved treatment; management is primarily supportive, often requiring intensive care and mechanical ventilation. Corticosteroids are commonly attempted but their usefulness is unestablished. Lung transplantation has shown benefit in selected advanced cases, with median post-transplant survival around five years. Prognosis is poor: 60% of patients die within six months, and survivors frequently experience recurrent episodes or chronic progressive lung disease. The disease's unknown cause distinguishes it from other forms of ARDS, and its historical recognition as Hamman–Rich syndrome underscores its long-standing clinical challenge.
Did You Know?
- Acute interstitial pneumonitis was first described in 1935 by Louis Hamman and Arnold Rich.
- The disease is also known as Hamman–Rich syndrome.
- Sixty percent of people with acute interstitial pneumonitis die within the first six months of illness.
- The median survival is 1+1⁄2 months.
Frequently Asked Questions
Who is Acute interstitial pneumonitis?
Acute interstitial pneumonitis is a rare, severe lung condition of unknown origin that targets previously healthy individuals, typically those over forty, with no sex-based preference. It is also commonly called Hamman–Rich syndrome after the two physicians who first documented it in 1935.
What are Acute interstitial pneumonitis's powers/role?
Its defining clinical 'power' is an extremely rapid escalation from the first respiratory symptoms to full-blown respiratory failure, often within just weeks. This fast-moving, trigger-free course is what separates it from chronic interstitial lung diseases like idiopathic pulmonary fibrosis.
How does Acute interstitial pneumonitis's story end?
Because no definitive cure has been identified, management is limited to supportive respiratory care rather than targeted therapy. The median survival from onset is roughly a month and a half, making the prognosis among the worst in pulmonology.
Why is Acute interstitial pneumonitis important?
It occupies a unique niche in respiratory medicine as a sudden, unexplained form of ARDS that cannot be attributed to infection, trauma, or other identifiable triggers. Recognizing it as a distinct entity—rather than lumping it in with chronic fibrotic lung disease—guides clinicians toward urgent supportive intervention.
What is Acute interstitial pneumonitis's origin/first appearance?
The condition was first formally described in 1935 by pulmonologists Louis Hamman and Arnold Rich, who published their observations of this rapidly fatal, idiopathic lung inflammation. Their names became the eponym 'Hamman–Rich syndrome,' which remains a standard alternative label in the literature.
More in Ailments of unknown cause 1-24
Spotted an error? Know more?
This is a living reference — every entry is fact-audited, and reader corrections feed straight into our audit queue. Suggest an edit · See this site's audit record